Correlation Between Microsoft and Zomedica Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and Zomedica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Zomedica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Zomedica Pharmaceuticals Corp, you can compare the effects of market volatilities on Microsoft and Zomedica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Zomedica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Zomedica Pharmaceuticals.

Diversification Opportunities for Microsoft and Zomedica Pharmaceuticals

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Microsoft and Zomedica is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Zomedica Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zomedica Pharmaceuticals and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Zomedica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zomedica Pharmaceuticals has no effect on the direction of Microsoft i.e., Microsoft and Zomedica Pharmaceuticals go up and down completely randomly.

Pair Corralation between Microsoft and Zomedica Pharmaceuticals

Given the investment horizon of 90 days Microsoft is expected to under-perform the Zomedica Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Microsoft is 4.47 times less risky than Zomedica Pharmaceuticals. The stock trades about -0.2 of its potential returns per unit of risk. The Zomedica Pharmaceuticals Corp is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  13.00  in Zomedica Pharmaceuticals Corp on October 7, 2024 and sell it today you would earn a total of  2.00  from holding Zomedica Pharmaceuticals Corp or generate 15.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Microsoft  vs.  Zomedica Pharmaceuticals Corp

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Zomedica Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Zomedica Pharmaceuticals Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Zomedica Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Microsoft and Zomedica Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and Zomedica Pharmaceuticals

The main advantage of trading using opposite Microsoft and Zomedica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Zomedica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zomedica Pharmaceuticals will offset losses from the drop in Zomedica Pharmaceuticals' long position.
The idea behind Microsoft and Zomedica Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume